MeVis Medical Solutions AG (FRA:M3V)
Germany flag Germany · Delayed Price · Currency is EUR
25.60
0.00 (0.00%)
At close: Jan 27, 2026

FRA:M3V Cash Flow Statement

Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
Net Income
4.564.927.794.555.7
Depreciation & Amortization
0.130.10.090.130.17
Other Operating Activities
-1.07-0.46-1.62-0.25-0.35
Change in Accounts Receivable
0.571.58-1.913.9-2.62
Change in Accounts Payable
-0.130.05-0.270.34-0.23
Change in Other Net Operating Assets
-0.91-0.320.770.460.21
Operating Cash Flow
3.155.854.869.132.89
Operating Cash Flow Growth
-46.25%20.52%-46.80%215.97%-55.84%
Capital Expenditures
-0.3-0.08-0.13-0.05-0.1
Investment in Securities
0.01----
Other Investing Activities
1.21.070.190.160.29
Investing Cash Flow
0.910.990.060.110.19
Other Financing Activities
-4.92-7.79-4.55-5.7-1.57
Financing Cash Flow
-4.92-7.79-4.55-5.7-1.57
Foreign Exchange Rate Adjustments
-0.35-0.631.330.13-0.15
Net Cash Flow
-1.22-1.581.73.671.35
Free Cash Flow
2.845.774.729.082.79
Free Cash Flow Growth
-50.74%22.23%-47.97%225.78%-56.05%
Free Cash Flow Margin
16.76%33.30%25.18%56.00%16.27%
Free Cash Flow Per Share
1.563.172.604.991.53
Cash Interest Paid
---0-
Cash Income Tax Paid
0.290.120.1700.35
Levered Free Cash Flow
2.434.282.759.07-2.66
Unlevered Free Cash Flow
2.434.282.759.07-2.66
Change in Working Capital
-0.471.3-1.414.71-2.63
Source: S&P Global Market Intelligence. Standard template. Financial Sources.